CompoAtlas

Ashwagandha KSM-66 Gummies

Food supplement declared in France, decision dated 14 October 2026

Ashwagandha KSM-66 Gummies (HealthyWorld®) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Withania somnifera 300 mg per day, Vitamin D. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
HealthyWorld®
Food business operator placing the product on the market
Be Healthy Group d.o.o.
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Gummy
Daily dose
2 gummies par jour
Directions for use
Dose journalière recommandée : 2 gummies. Il est recommandé de bien mâcher le bonbon avant de l'avaler.
Intended populations
Men and women aged 18 and over
Objectives stated by the manufacturer (these are not authorised claims)
Bones, Oral health, Immunity

Declaration 378531, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Withania somnifera (L.) DunalRacineAutre extrait sec300 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
ergocalciferolVitamin D100 µg (4,000 IU)5 µg (200 IU)

Additives

E331, E903, E270, E330, E440

Other ingredients

Raphanus sativus L., huile végétale, eau, sucre, sirop de glucose

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Avertissement : la quantité ou la dose journalière recommandée ne doit pas être dépassée. Les compléments alimentaires ne doivent pas remplacer une alimentation équilibrée et variée ainsi qu'un mode de vie sain. Tenir hors de portée des enfants ! Déconseillé aux enfants, aux femmes enceintes, aux mères allaitantes et aux personnes souffrant d'une hyperthyroïdie. Conserver dans un endroit sec, à l'abri de la lumière du soleil et de l'humidité, à une température inférieure à 25 °C.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Withania somnifera (L.) Dunal
    Read the warning, when it applies and the studies cited

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    Sources cited by Health Canada (3)
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    Sources cited by Health Canada (3)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
    • Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : HealthyWorld®

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Ashwagandha KSM-66 Gummies (HealthyWorld®): composition and regulation”, https://compoatlas.com/en/supplements/products/378531-ashwagandha-ksm-66-gummies, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line